Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsNatcopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Bull's Eye: Buy Sun Pharma, Pidilite, Alembic, SRF; Sell CESC

      Jay Thakkar of Anand Rathi Securities is of the view that one may buy Alembic with a target of Rs 48.70.

    • Sell UBL, Bharat Financial; buy Adani Ports, Petronet, Piramal Ent: Sukhani

      Sudarshan Sukhani of s2analytics.com suggests selling United Breweries and Bharat Financial Inclusion and advises buying Adani Ports, Petronet LNG and Piramal Enterprises.

    • Bull's Eye: Buy L&T, India Cements, PNB, BEML, Natco Pharma

      Sameet Chavan of Angel Broking suggests buying buying Larsen and Toubro (L&T) with a target of Rs 1645.

    • Buy Colgate Palmolive, Piramal Enterprises: Prakash Gaba

      Prakash Gaba of prakashgaba.com suggests buying Colgate Palmolive and Piramal Enterprises.

    • Buy Piramal Enterprises on declines: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that one may buy Piramal Enterprises on declines.

    • Buy MRPL, HPCL, HDFC, Piramal Enterprises: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com advises buying MRPL, HPCL, HDFC and Piramal Enterprises.

    • Bull's Eye: Buy Hind Zinc, Havells, Mawana Sugars, MOIL, HDIL

      Sameet Chavan of Angel Broking is of the view that one may buy Havells India with a target of Rs 35.

    • Bull's Eye: Buy DHFL, Ashok Leyland, Aban Offshore; sell CONCOR

      Ashish Kyal of Waves Strategy Advisors suggests buying Raymond with a target of Rs 670.

    • Buy, sell or hold: 9 stocks that analysts are bullish on

      Here are 9 stocks that brokerage firms' are bullish on. Morgan Stanley is overweight on Tata Motors with target price of Rs 585 per share. It expects volume to pick-up on XF launch in china & strong new discovery sales.

    • Bull's Eye: Buy Siemens, REC, HDIL, Colgate, Havells, PFC

      Ruchit Jain of Angel Broking is of the view that one may buy Rural Electrification Corporation with a target of Rs 174.

    • Sell Vedanta, Arvind; buy SKS Micro, Piramal Ent: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Vedanta, Arvind and Indiabulls Real Estate and advises buying SKS Microfinance and Piramal Enterprises.

    • Bull's Eye: Buy Syngene, Dabur, Divis Lab, PFC; sell NMDC

      Manas Jaiswal of manasjaiswal.com is of the view that one can buy ILandFS Investment Managers with a target of Rs 20 and Piramal Enterprises with a target of Rs 1210.

    • Hold Piramal Enterprises, says Nooresh Merani

      Nooresh Merani of Asian Market Securities is of the view that one may hold Piramal Enterprises.

    • Piramal Health, PNB may rally further: Murlidharan

      Manoj Murlidharan Vayalar, IIFL is of the view that Piramal Healthcare can go upto Rs 502, keeping a stop loss at Rs 482. Punjab National Bank can touch Rs 702 and Sun Pharma has target of Rs 686.

    • Piramal Healthcare can go upto Rs 490, says Vayalar

      Manoj Murlidharan Vayalar, Associate Vice President-Derivatives at IIFL PReMIA is of the view that, Piramal Healthcare is expected to go upto Rs 490, so one can keep a stop loss of Rs 465.

    • Tulsian picks media stocks for investments

      SP Tulsian of sptulsian.com, says that he is over all quite positive on media space. Dish TV can move up to Rs 80-85 especially because the kind of digitalization moves which is now likely to gather momentum and the stock will benefit. Apart form this he am positive on Hathway, DEN Network, Zee Entertainment and Sun TV.

    • Two pharma stocks that can improve health of your portfolio

      Ranbaxy and Cipla were at 52 week highs on Monday. Kour expects Cipla to perform well going ahead. She is bullish on this stock; however, she is cautious on Ranbaxy.

    • Aurobindo Pharma, Piramal Health can move up: Murlidharan

      Manoj Murlidharan Vayalar of IIFL is of the view that Aurobindo Pharma can move upto Rs 119 and Piramal Healthcare can touch Rs 523.

    • Piramal Health has target of Rs 600: Rajen Shah

      Piramal Healthcare has target of Rs 600 in the next 12-18 months, says Rajen Shah, CIO, Angel Broking.

    • Super Six stocks you can bet on Dec 30

      On CNBC-TV18's show Super Six, market gurus Hemen Kapadia CEO chartpundit.com, Vishal B Malkan, CMT, wwaw.malkansview.com and Nooresh Mirani - AVP Technical, AMSEC Research, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Piramal Healthcare may see 30% upside: PN Vijay

      Piramal Healthcare may see 30% upside, says PN Vijay, Portfolio Manager, pnvijay.com.

    • Super Six: Top chart picks for today

      On CNBC-TV18's show Super Six, market gurus Arunesh Madan, Founder and Director of Augment Investment, Nooresh Mirani, AMSEC and Vishal B Malkan, CMT, www.malkansview.com, place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Bull's Eye: Short Kingfisher, RCom; buy GMDC, United Phosp

      Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

    • Super Six: Manas, Vishal, Rajesh on their top picks

      On CNBC-TV18's show Super Six, market gurus Manas Jaiswal, Technical Analyst, manasjaiswal.com, Vishal Kshatriya, Sr. Derivative and Technical Analyst, Edelweiss and Rajesh Jain, EVP Reatail Research, Religare Sec place their bets on two stocks each, thus offering investors a variety of options to choose from.

    • Bajaj Hindusthan has target of Rs 42-43: Bhamre

      Bajaj Hindusthan has target of Rs 42-43, says Siddharth Bhamre of Angel Broking.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347